STereotactic Ablative RadioTherapy in NEWly Synchronous and mEtachRonous (Oligo-persistence, Oligo-induced, Oligo-progression) Oncogene and Non Oncogene Addicted OLIGO-metastatic Non-small Cell Lung Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06207292

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:21.696798+00:00

Published At

2024-01-16T00:00:00+00:00

Record Updated At

2024-01-16

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["NSCLC", "NSCLC Stage IV", "Oligometastatic Disease", "Non Small Cell Lung Cancer", "Non Small Cell Lung Cancer Metastatic", "EGF-R Positive Non-Small Cell Lung Cancer", "NSCLC Stage IV Without EGFR/ALK Mutation", "Non-Small Cell Adenocarcinoma", "Non-Small Cell Squamous Lung Cancer", "Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor", "Synchronous Metastases", "Metachronous Metastasis"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-01-16"

protocolSection.identificationModule.nctId

"NCT06207292"

protocolSection.identificationModule.officialTitle

"STereotactic Ablative RadioTherapy in NEWly Synchronous and mEtachRonous (Oligo-persistence, Oligo-induced, Oligo-progression) Oncogene and Non Oncogene Addicted OLIGO-metastatic Non-small Cell Lung Cancer Patients"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• NSCLC (protocolSection.conditionsModule.conditions)
• NSCLC Stage IV (protocolSection.conditionsModule.conditions)
• Oligometastatic Disease (protocolSection.conditionsModule.conditions)
• Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Non Small Cell Lung Cancer Metastatic (protocolSection.conditionsModule.conditions)
• EGF-R Positive Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• NSCLC Stage IV Without EGFR/ALK Mutation (protocolSection.conditionsModule.conditions)
• Non-Small Cell Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Non-Small Cell Squamous Lung Cancer (protocolSection.conditionsModule.conditions)
• Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (protocolSection.conditionsModule.conditions)
• Synchronous Metastases (protocolSection.conditionsModule.conditions)
• Metachronous Metastasis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.